Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R07 OTHER RESPIRATORY SYSTEM PRODUCTS
R07A OTHER RESPIRATORY SYSTEM PRODUCTS
R07AX Other respiratory system products
R07AX33 Deutivacaftor, tezacaftor and vanzacaftor
D13024 Vanzacaftor, tezacaftor and deutivacaftor
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D13024 Vanzacaftor, tezacaftor and deutivacaftor
Target-based classification of drugs [BR:br08310]
Transporters
ABC transporters
ABCC subfamily
CFTR* [HSA_VAR:1080v1]
D13024 Vanzacaftor, tezacaftor and deutivacaftor
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D13024
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D13024
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D13024
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D13024